We are live on
!
Find out more
KFO
Kopp Family Office Portfolio holdings
AUM
$163M
1-Year Est. Return
22.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
–
AUM
$171M
AUM Growth
+$13.2M
(+8.4%)
Cap. Flow
-$6.5M
Cap. Flow
% of AUM
-3.8%
Top 10 Holdings %
Top 10 Hldgs %
91.93%
Holding
21
New
–
Increased
1
Reduced
11
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$2.48M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.74M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.31M |
| 4 |
JAMF
Jamf
JAMF
|
+$1.26M |
| 5 |
FIVE9
FIVN
|
+$852K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 24.58% |
| 3 | Communication Services | 3.37% |
Similar funds
OFM
PCR
TCGDR
IPWA
IVGAI
CC
GP
PWAM
Kopp Family Office's Q4 2023 Portfolio in Review
As of Q4 2023, Kopp Family Office held 21 positions worth $171M, up 8.4% from $158M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Kopp Family Office withdrew a net $6.5M in Q4 2023, reducing 11 holdings. Its largest reduction was NeoGenomics, cutting an estimated $2.48M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Kopp Family Office added an estimated $2.45M to Inspire Medical Systems.
- Kopp Family Office added most to Inspire Medical Systems in Q4 2023, an estimated $2.45M increase.
- Kopp Family Office's biggest Q4 2023 reduction was NeoGenomics, cutting an estimated $2.48M.
- Kopp Family Office's ten largest holdings make up 92% of its $171M portfolio in Q4 2023.
- Kopp Family Office opened 0 new positions and closed 0 in Q4 2023.
- Kopp Family Office's portfolio value rose 8.4% quarter-over-quarter to $171M.
Based on Kopp Family Office's 13F filing for Q4 2023, filed 13 Feb 2024.